Logo Inventiva Pharma
  • About Inventiva
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Our people
  • Therapeutic Areas
    • Non-alcoholic steatohepatitis (NASH)
    • Mucopolysaccharidosis (MPS)
    • Publications
    • PanNASH Initiative
  • Pipeline
    • Lanifibranor
    • Odiparcil
    • YAP-TEAD
    • Clinical Trials
    • Our Partners
    • Inventiva Expanded Access Policy
  • Investors
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financial Calendar
    • Results & Presentations
    • Investor Presentations
    • Regulated Information
    • Shareholder Meetings
    • Stock Market Data
      • Stock Quote – Euronext Paris
      • Stock Chart – Euronext Paris
      • Stock Quote – NASDAQ
      • Historic Price Lookup
      • Investment Calculator
    • SEC Filings
    • Share Information
    • Analyst Coverage
    • Investor Resources
      • IR Contacts
  • News & Events
  • Contact Us
  • Fr
  • En
Email alerts
Home - Email alerts

About Inventiva

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology.

Jump to

  • Legal information
  • Contact Us
  • Home
  • Legal information
  • Contact Us

© 2021 Inventiva. All rights reserved. Privacy Policy – Legal Information

Email alerts